MSTN and proximal spinal muscular atrophy: Similarly, Zhou et al. reported that myostatin inhibition synergistically enhanced the effects of Survival motor neuron 1-restoring antisense therapy, leading to increased muscle mass, improved motor function, and extended survival in spinal muscular atrophy (SMA) mice [33].